Literature DB >> 19962960

Role of the tumor suppressor RASSF2 in regulation of MST1 kinase activity.

Hoogeun Song1, Sangphil Oh, Hyun Jung Oh, Dae-Sik Lim.   

Abstract

The tumor suppressor, RASSF2 (Ras association domain family 2), is frequently downregulated in a number of cancers. Although exogenously expressed RASSF2 induces apoptotic cell death, the precise roles of RASSF2 under pro-apoptotic conditions remain largely unknown. Here, we demonstrate that MST1 (mammalian sterile 20-like kinase 1) regulates RASSF2 protein stability. Knockdown of MST1 in cancer cells markedly destabilizes RASSF2, and Mst1-deficient mice show reduced Rassf2 protein levels in several organs. Conversely, RASSF2 activates MST1 kinase activity through formation of a RASSF2-MST1 complex, which inhibits the MST-FOXO3 signaling pathway. RASSF2 also engages the JNK pathway and induces apoptosis in an MST1-independent manner. Collectively, these findings indicate that MST1 is a major determinant of RASSF2 protein stability, and suggest that RASSF2 acts in a complex manner that extends beyond simple protein-protein association to play an important role in MST1 regulation. Copyright 2009. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19962960     DOI: 10.1016/j.bbrc.2009.11.175

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  29 in total

Review 1.  STRIPAK complexes in cell signaling and cancer.

Authors:  Z Shi; S Jiao; Z Zhou
Journal:  Oncogene       Date:  2016-02-15       Impact factor: 9.867

Review 2.  Regulation of mammalian Ste20 (Mst) kinases.

Authors:  Sonali J Rawat; Jonathan Chernoff
Journal:  Trends Biochem Sci       Date:  2015-02-06       Impact factor: 13.807

3.  The dynamic mechanism of RASSF5 and MST kinase activation by Ras.

Authors:  Tsung-Jen Liao; Hyunbum Jang; Chung-Jung Tsai; David Fushman; Ruth Nussinov
Journal:  Phys Chem Chem Phys       Date:  2017-03-01       Impact factor: 3.676

4.  Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma.

Authors:  Wei Guo; Zhiming Dong; Jianli Cui; Yanli Guo; Supeng Shen; Xin Guo; Gang Kuang
Journal:  Clin Exp Metastasis       Date:  2016-01       Impact factor: 5.150

Review 5.  The mammalian Hippo pathway: regulation and function of YAP1 and TAZ.

Authors:  Manami Kodaka; Yutaka Hata
Journal:  Cell Mol Life Sci       Date:  2014-09-30       Impact factor: 9.261

6.  The RASSF6 tumor suppressor protein regulates apoptosis and the cell cycle via MDM2 protein and p53 protein.

Authors:  Hiroaki Iwasa; Takumi Kudo; Sainawaer Maimaiti; Mitsunobu Ikeda; Junichi Maruyama; Kentaro Nakagawa; Yutaka Hata
Journal:  J Biol Chem       Date:  2013-09-03       Impact factor: 5.157

7.  H-ras Inhibits the Hippo Pathway by Promoting Mst1/Mst2 Heterodimerization.

Authors:  Sonali J Rawat; Daniela Araiza-Olivera; Luis E Arias-Romero; Olga Villamar-Cruz; Tatiana Y Prudnikova; Heinrich Roder; Jonathan Chernoff
Journal:  Curr Biol       Date:  2016-05-26       Impact factor: 10.834

8.  The tumor suppressor Mst1 promotes changes in the cellular redox state by phosphorylation and inactivation of peroxiredoxin-1 protein.

Authors:  Sonali Jalan Rawat; Caretha L Creasy; Jeffrey R Peterson; Jonathan Chernoff
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

9.  Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences.

Authors:  Undraga Schagdarsurengin; Antje M Richter; Juliane Hornung; Cornelia Lange; Katrin Steinmann; Reinhard H Dammann
Journal:  Mol Cancer       Date:  2010-09-29       Impact factor: 27.401

10.  Ectopic expression of RASSF2 and its prognostic role for gastric adenocarcinoma patients.

Authors:  Deng Luo; Ting Ye; Tian-Qian Li; Peng Tang; Sha-Dong Min; Gong-Fang Zhao; Hua Huang; Jiang Chang; Yan Wang; Lin Lv; Ming-Liang Lu; Meng-Yao Zheng
Journal:  Exp Ther Med       Date:  2011-12-28       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.